Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: In vivo and in vitro studies

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4379-4389

  Zhang, Hang Zhou ^a   Sun, Yu ^a   Tian, Ang ^b   Xue, Xiang Xin ^b   Wang, Lin ^a   Alquhali, Ali ^a   Bai, Xi Zhuang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

Author keywords

Antibacterial properties; Biocompatibility; Osteoblasts; TiO2 nanotubes; Vancomycin

Indexed keywords

NANOTUBE; TITANIUM DIOXIDE; TITANIUM DIOXIDE NANOTUBE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; BACTERIUM CONTAMINATION; BIOCOMPATIBILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE INFECTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFECTION RATE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NANOFABRICATION; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOBLAST; RAT; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS;

ANTIBACTERIAL PROPERTIES; BIOCOMPATIBILITY; OSTEOBLASTS; TIO2 NANOTUBES; VANCOMYCIN;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CELL PHYSIOLOGICAL PROCESSES; FEMUR; MATERIALS TESTING; MICE; NANOTUBES; PROSTHESES AND IMPLANTS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCUS AUREUS; TITANIUM; VANCOMYCIN;

EID: 84887358143     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S53221     Document Type: Article

References (38)

1. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422-1429.
2. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23(7):984-991.
3. Green SA. Complications of external skeletal fixation. Clin Orthop Relat Res. 1983;(180):109-116.
4. Poelstra KA, Barekzi NA, Rediske AM, Felts AG, Slunt JB, Grainger DW. Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies. J Biomed Mater Res. 2002;60(1):206-215.
5. Ribeiro M, Monteiro FJ, Ferraz MP. Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter. 2012;2(4):176-194.
6. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318-1322.
7. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2(2):114-122.
8. Popat KC, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants? Small. 2007;3(11):1878-1881.
9. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37 Suppl 2:S95-S104.
10. Gulati K, Aw MS, Findlay D, Losic D. Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays. Ther Deliv. 2012;3(7):857-873.
11. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand. 2001;72(6):557-571.
12. Berger RA, Jacobs JJ, Quigley LR, Rosenberg AG, Galante JO. Primary cementless acetabular reconstruction in patients younger than 50 years old. 7-to 11-year results. Clin Orthop Relat Res. 1997;(344):216-226.
13. Albrektsson T, Sennerby L. Direct bone anchorage of oral implants: clinical and experimental considerations of the concept of osseointegration. Int J Prosthodont. 1990;3(1):30-41.
14. von der Mark K, Park J, Bauer S, Schmuki P. Nanoscale engineering of biomimetic surfaces: cues from the extracellular matrix. Cell Tissue Res. 2010;339(1):131-153.
15. 2 nanotube surface. Acta Biomater. 2009;5(8):3215-3223.
16. 2 nanotubes: an experimental study in the pig. J Biomed Mater Res B Appl Biomater. 2009;89(1):165-171.
17. 2 nanotubes with different diameters on gene expression and osseointegration of implants in minipigs. Biomaterials. 2011;32(29):6900-6911.
18. Bjursten LM, Rasmusson L, Oh S, Smith GC, Brammer KS, Jin S. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A. 2010;92(3):1218-1224.
19. Eaninwene G 2nd, Yao C, Webster TJ. Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int J Nanomedicine. 2008;3(2):257-264.
20. 2 nanotubes. J Biomed Mater Res A. 2006;78(1):97-103.
21. Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials. 2007;28(21): 3188-3197.
22. Sollazzo V, Pezzetti F, Scarano A, et al. Anatase coating improves implant osseointegration in vivo. J Craniofac Surg. 2007;18(4):806-810.
23. Gulati K, Aw MS, Losic D. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. Nanoscale Res Lett. 2011;6:571.
24. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus Epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials. 2007;28(32): 4880-4888.
25. Ercan B, Taylor E, Alpaslan E, Webster TJ. Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology. 2011;22(29):295102.
26. 2 nanotube diameter directs cell fate. Nano Lett. 2007;7(6):1686-1691.
27. Wei H, Wu S, Feng Z, et al. Increased fibroblast functionality on CNN2-loaded titania nanotubes. Int J Nanomedicine. 2012;7: 1091-1100.
28. Arciola CR, Campoccia D, Gamberini S, et al. Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections. Biomaterials. 2005;26(33): 6530-6535.
29. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996;(333):245-251.
30. Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res. 2011;29(7):1070-1074.
31. 2 nanotube arrays deposited on Ti substrate by anodic oxidation and their potential as a long-term drug delivery system for antimicrobial agents. Appl Surf Sci. 2012;258(14):5399-5404.
32. Gulati K, Ramakrishnan S, Aw MS, Atkins GJ, Findlay DM, Losic D. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomater. 2012;8(1): 449-456.
33. Yao C, Webster TJ. Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method. J Biomed Mater Res B Appl Biomater. 2009;91(2):587-595.
34. 2 nanotubes as drug nanoreservoirs for the regulation of mobility and differentiation of mesenchymal stem cells. Acta Biomater. 2012;8(1):439-448.
35. Puckett SD, Taylor E, Raimondo T, Webster TJ. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials. 2010;31(4):706-713.
36. Hendriks JG, Neut D, van Horn JR, van der Mei HC, Busscher HJ. Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. J Bone Joint Surg Br. 2005;87(2):272-276.
37. Oh S, Brammer KS, Li YS, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A. 2009;106(7): 2130-2135.
38. 2 nanotube surfaces. Nano Lett. 2008;8(3):786-793.